Nurse Practitioner, Acute Care · Baltimore, MD
NPI
1427350628
Since 2010
Specialty
Nurse Practitioner, Acute Care
Code 363LA2100X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
22 S Greene St
Baltimore, MD, 21201
Phone (410) 328-2302
Groups this clinician bills Medicare through
Medicare paid, 2024
$39K
685 services
Medicare patients, 2024
167
Average age 69
Drug cost, 2024
$7.6M
2,716 prescriptions
Company payments, 2025
$214
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Loida A Johnson was code 99214 (office e&m - established), 377 times for 153 patients. In total Loida A Johnson billed 685 services in 8 codes, and Medicare paid $39K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-02-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 377 | 153 | $83.31 | $31K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 265 | 122 | $11.14 | $2,951 |
| 99204 Office E&M - New | Office | 25 | 25 | $109.64 | $2,741 |
By year: 2022 $40K for 469 services; 2023 $43K for 483 services; 2024 $39K for 685 services.
Medicare prescription drug claims, 2024
In 2024, the drug Loida A Johnson prescribed most often to Medicare patients was Sildenafil Citrate, with 189 prescriptions and refills. In total Loida A Johnson wrote 2,716 Medicare prescriptions that cost $7.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Sildenafil Citrate Generic | 189 | 227 | 34 | $72K |
| Spironolactone Generic | 189 | 465 | 58 | $1,698 |
| Adempas Riociguat | 162 | 162 | 17 | $2.2M |
| Furosemide Generic | 155 | 358 | 53 | $1,213 |
| Tadalafil Generic | 120 | 137 | 16 | $229K |
| Eliquis Apixaban | 118 | 215 | 26 | $121K |
| Opsumit Macitentan | 112 | 112 | 13 | $1.4M |
| Metoprolol Succinate Generic | 111 | 256 | 27 | $2,397 |
| Potassium Chloride Generic | 102 | 215 | 36 | $3,003 |
| Digoxin Generic | 95 | 257 | 31 | $1,541 |
| Orenitram Er Treprostinil Diolamine | 80 | 80 | Under 11 | $514K |
| Ambrisentan Generic | 77 | 85 | 11 | $332K |
| Torsemide Generic | 73 | 143 | 24 | $1,847 |
| Atorvastatin Calcium Generic | 72 | 180 | 25 | $1,125 |
| Uptravi Selexipag | 65 | 65 | Under 11 | $1.1M |
Brand drugs: 844 claims; generic drugs: 1,872 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Loida A Johnson $214 ($214 in general payments such as food, travel and fees) from 1 company. The largest payer was Bayer Healthcare Pharmaceuticals Inc. with $214.
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 2 | $214 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.